EpiPen supply issues to continue indefinitely

While Pfizer is working to achieve ongoing availability, it reportedly cannot commit to a specific time when the supply constraint will be fully resolved Mylan/Alphapharm, the sponsor of EpiPens, has again confirmed there are “intermittent supply constraints” of EpiPen 300mcg Adrenaline (epinephrine) auto-injectors due to manufacturing delays from Pfizer’s Meridian Medical Technologies. While thousands of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The week in review
Next TGA well trusted by stakeholders: survey